ENSEM Therapeutics
About:
ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets
Website: http://www.ensemtx.com/
Top Investors: Pavilion Capital, MegaRobo, Mitsui & Co, GGV Capital, Legend Star
Description:
ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.
Total Funding Amount:
$77M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Medford, Massachusetts, United States
Founded Date:
2021-01-01
Contact Email:
info(AT)ensemtx.com
Founders:
Shengfang Jin
Number of Employees:
11-50
Last Funding Date:
2023-10-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai